One way to identify the patients likely to respond to immunotherapy is by identifying the distribution of inflammatory cells relative to tumor cells. However, in spite of the compelling association of immune phenotypes with clinical outcome, there are not yet standard definitions or scoring methods.

See how our scientists developed a method for pathologists to identify desert, excluded and inflamed immune phenotypes in our new video!

Want more details? Read the poster!